KUNGSBACKA, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): Net sales increased by 9 percent to SEK 141.4 (129.5) million. Adjusted for exchange rate effects, the increase was 12 percent. During the third quarter sales amounted to SEK 44.6 (41.0) million, corresponding to an increase of 9 percent. Adjusted for negative exchange rate effects, the increase was 12 percent.
